PHSA 17073 - Ascyrus Medical Dissection Stent (AMDS) Hybrid Prosthesis for Kelowna General Hospital, Vancouver General Hospital and Royal Jubilee Hospital (Канада - Тендер #71080345) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Канада (другие тендеры и закупки Канада) Организатор тендера: www.merx.com Номер конкурса: 71080345 Дата публикации: 05-03-2026 Источник тендера: www.merx.com |
||
Seeking a supplier for the Ascyrus Medical Dissection Stent (AMDS) device, which has been demonstrated to be safe and reduce mortality in Type A Dissection cases complicated by malperfusion.
00004929838
Issuing OrganizationProvincial Health Services Authority BC
Solicitation TypeNOI - Notice of Intent (Informal)
Solicitation NumberPHSA 17073
TitleAscyrus Medical Dissection Stent (AMDS) Hybrid Prosthesis for Kelowna General Hospital, Vancouver General Hospital and Royal Jubilee Hospital
Source IDSCRIBE
British Columbia
Purchase TypeNot Stated
2026/03/04 08:45:00 AM EST
Closing Date2026/03/13 05:00:00 PM EDT
Arman Rusheeq Uddin
arman.uddin@phsa.ca
The AMDS device has been demonstrated in many large series to be safe and reduce mortality compared to historical control in Type A Dissection complicated by malperfusion. Favorable aortic
remodeling has also been widely reported. The device has been approved in Canada and Europe. FDA has granted a Humanitarian Device Exemption (HDE) for use of the AMDS Hybrid Prosthesis
(AMDS).
Artivion, Inc. dba CryoLife Canada, Inc. is the only supplier in the market that manufactures, market, sell and distribute Ascyrus Medical Dissection Stent (AMDS) device which is Health Canada
approved.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Arman Rusheeq Uddin, Buyer – Cardiac care by email before 2:00pm
Pacific Time, March 13, 2026. PHSA will review all issues received by this date and provide due consideration to each objection.
Please Reference File: # PHSA 17073 on all written correspondence.